First Trust Direct Indexing L.P. Grows Position in Revvity, Inc. (NYSE:RVTY)

First Trust Direct Indexing L.P. raised its position in Revvity, Inc. (NYSE:RVTY) by 36.3% during the 3rd quarter, Holdings Channel reports. The firm owned 2,983 shares of the company’s stock after acquiring an additional 794 shares during the quarter. First Trust Direct Indexing L.P.’s holdings in Revvity were worth $381,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of RVTY. EdgePoint Investment Group Inc. acquired a new stake in Revvity in the second quarter valued at $209,221,000. Jane Street Group LLC grew its holdings in Revvity by 516.4% in the first quarter. Jane Street Group LLC now owns 453,343 shares of the company’s stock valued at $47,601,000 after purchasing an additional 379,802 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in Revvity by 18.5% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,126,271 shares of the company’s stock valued at $223,258,000 after purchasing an additional 332,632 shares during the last quarter. Janus Henderson Group PLC grew its holdings in Revvity by 3.9% in the first quarter. Janus Henderson Group PLC now owns 5,664,528 shares of the company’s stock valued at $594,769,000 after purchasing an additional 210,100 shares during the last quarter. Finally, Coronation Fund Managers Ltd. grew its holdings in Revvity by 261.3% in the first quarter. Coronation Fund Managers Ltd. now owns 253,722 shares of the company’s stock valued at $26,641,000 after purchasing an additional 183,490 shares during the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

Analyst Ratings Changes

Several analysts have weighed in on the company. Leerink Partners upped their target price on Revvity from $130.00 to $135.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Bank of America increased their price objective on Revvity from $118.00 to $127.00 and gave the company a “neutral” rating in a research note on Tuesday, July 30th. Citigroup increased their price objective on Revvity from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, July 30th. Barclays raised Revvity from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $125.00 to $140.00 in a research note on Tuesday, October 15th. Finally, Wells Fargo & Company assumed coverage on Revvity in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $130.00 price objective on the stock. Seven research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $128.79.

Revvity Stock Up 2.1 %

Shares of NYSE:RVTY opened at $121.04 on Monday. The stock’s 50-day moving average price is $121.39 and its two-hundred day moving average price is $114.11. The company has a current ratio of 2.27, a quick ratio of 1.98 and a debt-to-equity ratio of 0.40. Revvity, Inc. has a 12-month low of $82.17 and a 12-month high of $128.15. The firm has a market cap of $14.93 billion, a price-to-earnings ratio of 87.71, a PEG ratio of 3.27 and a beta of 1.06.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 7th. Stockholders of record on Friday, January 17th will be issued a $0.07 dividend. The ex-dividend date is Friday, January 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.23%. Revvity’s dividend payout ratio (DPR) is 20.29%.

Insider Transactions at Revvity

In other news, insider Tajinder S. Vohra sold 2,153 shares of the firm’s stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $122.09, for a total value of $262,859.77. Following the transaction, the insider now directly owns 23,960 shares in the company, valued at $2,925,276.40. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, insider Tajinder S. Vohra sold 2,153 shares of the firm’s stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $122.09, for a total value of $262,859.77. Following the transaction, the insider now directly owns 23,960 shares in the company, valued at $2,925,276.40. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Tajinder S. Vohra sold 2,154 shares of the firm’s stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $121.73, for a total value of $262,206.42. Following the completion of the transaction, the insider now owns 19,652 shares in the company, valued at approximately $2,392,237.96. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 7,807 shares of company stock worth $937,576 in the last three months. 0.60% of the stock is currently owned by company insiders.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.